Adrenal Tumors - Pathogenesis and Therapy
This study is currently recruiting participants.
Verified July 2010 by University of Wuerzburg
Sponsor:
University of Wuerzburg
Collaborators:
Deutsche Krebshilfe e.V., Bonn (Germany)
German Federal Ministry of Education and Research
Information provided by:
University of Wuerzburg
ClinicalTrials.gov Identifier:
NCT00669266
First received: April 28, 2008
Last updated: July 6, 2010
Last verified: July 2010
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | April 28, 2008 | ||||
| Last Updated Date | July 6, 2010 | ||||
| Start Date ICMJE | September 2002 | ||||
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE | |||||
| Original Primary Outcome Measures ICMJE | |||||
| Change History | Complete list of historical versions of study NCT00669266 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | |||||
| Original Secondary Outcome Measures ICMJE | |||||
| Current Other Outcome Measures ICMJE | |||||
| Original Other Outcome Measures ICMJE | |||||
| Descriptive Information | |||||
| Brief Title ICMJE | Adrenal Tumors - Pathogenesis and Therapy | ||||
| Official Title ICMJE | Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen | ||||
| Brief Summary | The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma. |
||||
| Detailed Description | |||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case Control | ||||
| Biospecimen | Retention: Samples With DNA Description: Germline DNA Tumor samples Serum Plasma Urine |
||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Patients with adrenal tumors |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | |||||
| Study Group/Cohort (s) |
|
||||
| Publications * | |||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 500 | ||||
| Estimated Completion Date | December 2013 | ||||
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria: |
||||
| Gender | Both | ||||
| Ages | |||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Germany | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00669266 | ||||
| Other Study ID Numbers ICMJE | Wue-Adrenal-Tumors-92/2002 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Martin Fassnacht, MD, University of Wuerzburg | ||||
| Study Sponsor ICMJE | University of Wuerzburg | ||||
| Collaborators ICMJE |
|
||||
| Investigators ICMJE |
|
||||
| Information Provided By | University of Wuerzburg | ||||
| Verification Date | July 2010 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||
